We observed that enhancing O-GlcNAcylation of FTO using an OGA inhibitor (TMG) decreased LPS-induced TNF-α/IL-1β/IL-6 inflammation and reduced septic mouse mortality, which may constitute a protective mechanism to limit exacerbated inflammation in acute stress conditions such as LPS-induced sepsis. The gene discussed is FTO; the disease is Sepsis.